(E)-Isoeugenol is a phenylpropanoid occurring as a minor constituent of essential oils, with floral, clove-like, carnation, spicy odor character.
Aroma and practical use
- Use the recorded floral, clove-like, carnation, spicy, sweet, woody descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
There are no constituent-specific outcome findings in this report. No therapeutic benefit is inferred from its presence.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
recorded reference · IFRA Standard, Isoeugenol (CAS 5932-68-3), Amendment 49 (2020), IFRA_STD_048; restriction driven by dermal sensitization. Document existence and restricted-material status corroborated via IFRA standards library and RIFM fragrance ingredient safety assessment (isoeugenol, CAS 97-54-1 family) on this pass; exact Category 5A digit could not be re-extracted from the source PDF (encoded/non-text layout) so is carried forward from the prior citation rather than independently re-derived.Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (3)
- Minor/trace constituent; full profile and SEO detail pending.
- No constituent-specific outcome findings are available in this report.
- No public source links are attached to this constituent report.